sun yang

Dr. sun yang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2023 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
XCXiaoxiao Cheng
Xiaoxiao Cheng
QXQirong Xie
Qirong Xie
SYsun yang
sun yang
Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and biological properties. By combining therapeutic drugs with nanoparticles using rational targeting pathways, nano-targeted delivery systems were created to overcome the main drawbacks of conventional drug treatment, including insufficient stability and solubility, lack of transmembrane transport, short circulation time, and undesirable toxic effects. Herein, we reviewed the recent developments in different targeting design strategies and therapeutic approaches employing various nanomaterial-based systems. We also discussed the challenges and perspectives of smart systems in precisely targeting different intravascular and extravascular diseases.

1 January 2017 in Theranostics
Verified
Journal Article
Open access
LDLiming Deng
Liming Deng
XCXiaojun Cai
Xiaojun Cai
DSDanli Sheng
Danli Sheng
YYYang Yang
Yang Yang
ESEric M. Strohm
Eric M. Strohm
SYsun yang
sun yang
Multifunctional nanoparticles have been reported for cancer detection and treatment currently. However, the accurate diagnosis and efficient treatment for tumors are still not satisfied. Here we report on the development of targeted phase change multimodal polymeric nanoparticles for the imaging and treatment of HER2-positive breast cancer.

11 August 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
JYJianting Yao
Jianting Yao
ZYZhuowen Yang
Zhuowen Yang
LHLiandi Huang
Liandi Huang
CYChao Yang
Chao Yang
JWJianxin Wang
Jianxin Wang
HRHaitao Ran
Haitao Ran
Pathological angiogenesis is a crucial factor that causes atherosclerotic plaque rupture. Sinoporphyrin sodium‐mediated sonodynamic therapy (DVDMS‐SDT) induces regression of plaque neovascularization in humans without causing obvious side effects. However, a clinical noninvasive theranostic strategy for atherosclerotic plaque neovascularization is urgently needed. A nanoplatform designed for multimodality imaging‐guided SDT in plaque angiogenesis theranostics, termed PFP–HMME@PLGA/MnFe2O4–ramucirumab nanoparticles (PHPMR NPs), is fabricated. It encapsulates manganese ferrite (MnFe2O4), hematoporphyrin monomethyl ether (HMME), and perfluoropentane (PFP) stabilized by polylactic acid‐glycolic acid (PLGA) shells and is conjugated to an anti‐VEGFR‐2 antibody. With excellent magnetic resonance imaging (MRI)/photoacoustic/ultrasound imaging ability, the distribution of PHPMR NPs in plaque can be observed in real time. Additionally, they actively accumulate in the mitochondria of rabbit aortic endothelial cells (RAECs), and the PHPMR NP‐mediated SDT promotes mitochondrial‐caspase apoptosis via the production of reactive oxygen species and inhibits the proliferation, migration, and tubulogenesis of RAECs. On day 3, PHPMR NP‐mediated SDT induces apoptosis in neovessel endothelial cells and improves hypoxia in the rabbit advanced plaque. On day 28, PHPMR NP‐mediated SDT reduces the density of neovessels, subsequently inhibiting intraplaque hemorrhage and inflammation and eventually stabilizing the plaque. Collectively, PHPMR NP‐mediated SDT presents a safe and effective theranostic strategy for inhibiting plaque angiogenesis.

9 February 2023 in Biomaterials Research
Verified
Journal Article
Open access
PDF file
JZJun Zheng
Jun Zheng
JHJu Huang
Ju Huang
LZLiang Zhang
Liang Zhang
MWMengna Wang
Mengna Wang
LXLihong Xu
Lihong Xu
ZWzhigang wang
zhigang wang
Background: Although programmed cell death protein 1 (PD-1)/ programmed cell death-ligand protein 1 (PD-L1) checkpoint blockade immunotherapy demonstrates great promise in cancer treatment, poor infiltration of T cells resulted from tumor immunosuppressive microenvironment (TIME) and insufficient accumulation of anti-PD-L1 (αPD-L1) in tumor sites diminish the immune response. Herein, we reported a drug-loaded microbubble delivery system to overcome these obstacles and enhance PD-L1 blockade immunotherapy. Methods: Docetaxel (DTX) and imiquimod (R837)-loaded microbubbles (RD@MBs) were synthesized via a typical rotary evaporation method combined with mechanical oscillation. The targeted release of drugs was achieved by using the directional "bursting" capability of ultrasound-targeted microbubble destruction (UTMD) technology. The antitumor immune response by RD@MBs combining αPD-L1 were evaluated on 4T1 and CT26 tumor models. Results: The dying tumor cells induced by DTX release tumor-associated antigens (TAAs), together with R837, promoted the activation, proliferation and recruitment of T cells. Besides, UTMD technology and DTX enhanced the accumulation of αPD-L1 in tumor sites. Moreover, RD@MBs remolded TIME, including the polarization of M2-phenotype tumor-associated macrophages (TAMs) to M1-phenotype, and reduction of myeloid-derived suppressor cells (MDSCs). The RD@MBs + αPD-L1 synergistic therapy not only effectively inhibited the growth of primary tumors, but also significantly inhibited the mimic distant tumors as well as lung metastases. Conclusion: PD-L1 blockade immunotherapy was enhanced by RD@MBs delivery system.

21 March 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
RHRongzhong Huang
Rongzhong Huang
LZLujun Zhang
Lujun Zhang
XLXingsheng Li
Xingsheng Li
FLFan Liu
Fan Liu
XCXiaoxiao Cheng
Xiaoxiao Cheng
SYsun yang
sun yang

29 October 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
LDLiming Deng
Liming Deng
DSDanli Sheng
Danli Sheng
MLMingzhu Liu
Mingzhu Liu
LYLu Yang
Lu Yang
HRHaitao Ran
Haitao Ran
ZWzhigang wang
zhigang wang
Synergistic photodynamic therapy of mitochondria-targeting and O2 self-supply can be achieved in a sample near-infrared laser and H2O2 activated bio-nanoreactor.